by Admin | January 3, 2018 3:06 pm
[1]January 3, 2018—Pharmaceutical companies may have misclassified 885 drugs for Medicaid drug rebate purposes in 2016, with the top 10 in terms of highest total reimbursement accounting for potentially $1.3 billion in lost Medicaid drug rebates, the U.S. Department of Health and Human Services Office of Inspector General (OIG) reports. Four drug manufacturers were responsible for more than half (54 percent) of the potential misclassifications and 90 percent of the claims involved only two drugs.
Source URL: https://340binformed.org/2018/01/drug-companies-may-owe-medicaid-1-3-billion-in-unpaid-rebates/
Copyright ©2024 340binformed.org unless otherwise noted.